CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Beginning balance at Dec. 31, 2021	$ 3	$ 346,312	$ (160,886)	$ 185,429
Beginning balance (in shares) at Dec. 31, 2021	27,358,375
Stockholders' Deficit
Vesting of restricted common stock (in shares)	64,415
Exercise of stock options		16		16
Exercise of stock options (in shares)	2,657
Stock-based compensation expense		8,424		8,424
Net Income (Loss)			(88,222)	(88,222)
Ending balance at Dec. 31, 2022	$ 3	354,752	(249,108)	105,647
Ending balance (in shares) at Dec. 31, 2022	27,425,447
Stockholders' Deficit
Issuance of common stock under employee stock purchase plan		194		194
Issuance of common stock under employee stock purchase plan (in shares)	140,192
Vesting of restricted common stock (in shares)	39,250
Exercise of stock options		8		$ 8
Exercise of stock options (in shares)	2,757			2,757
Stock-based compensation expense		7,382		$ 7,382
Net Income (Loss)			(76,404)	(76,404)
Ending balance at Dec. 31, 2023	$ 3	$ 362,336	$ (325,512)	$ 36,827
Ending balance (in shares) at Dec. 31, 2023	27,607,646